Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3020047	s-hibab	— (—)	36	45	100.00%	Distribution not available
3020047	s-hibab	mg/l (—)	31	38	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

13.62

33.38

1.5

1.1

—

Immunodeficiencies

+∞

28.19

1.5

0.0

—

Immunodeficiency with predominantly antibody defects

+∞

18.81

1.7

0.0

—

Cough

10.97

14.59

1.6

1.4

—

Fever of other and unknown origin

10.60

14.02

1.5

1.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

9.92

12.93

1.7

1.1

—

9.92

12.93

1.7

1.1

—

Other septicaemia

10.57

12.57

1.4

1.3

—

Other and unspecified immunodeficiencies with predominantly antibody defects

+∞

12.56

1.8

0.0

—

Pneumonias (Asthma/COPD co-morbidities)

5.77

12.00

1.6

1.2

—

Septicaemia

8.10

11.78

1.3

1.4

—

Explicit Sepsis

8.08

11.74

1.3

—

Influenza and pneumonia

5.51

11.69

1.5

1.2

—

Kela reimbursement Agammaglobulinemia (D80-84)

+∞

11.53

1.5

0.0

—

All pneumoniae

5.39

11.24

1.6

1.2

—

Asthma-related pneumonia

8.74

11.09

1.4

1.3

—

Pneumonia, organism unspecified

5.89

10.98

1.6

1.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5.44

10.81

1.5

1.3

—

Asthma-related pneumonia or sepsis

8.23

10.59

1.4

—

Asthma, hospital admissions 3, pneumonia

8.23

10.59

1.4

—

Acute upper respiratory infections

7.52

10.23

1.6

1.2

—

Intestinal infectious diseases

5.04

9.70

1.3

1.4

—

Asthma-related infections

5.37

9.22

1.3

1.4

—

Asthma, hospital admission 2, infections

5.37

9.22

1.3

1.4

—

Acute upper respiratory infections of multiple and unspecified sites

8.07

9.14

1.6

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

5.90

8.92

1.4

—

ILD medications: immunosuppressive drugs

6.26

8.85

1.7

1.4

—

5.27

8.57

1.4

—

Diarrhoea and gastroenteritis of presumed infectious origin

5.11

8.53

1.3

1.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4.55

8.37

1.6

1.2

—

Other immunodeficiencies

+∞

8.36

1.4

0.0

—

Acute sinusitis

18.65

8.14

1.3

—

GASTRO-related operations

5.96

8.07

1.4

1.3

—

Any gastric operation

5.96

8.07

1.4

1.3

—

5.94

7.83

1.6

1.2

—

Otitis media, unspecified

7.80

7.66

1.4

1.3

—

Deposits [accretions] on teeth

7.61

7.65

1.8

1.4

—

COPD/asthma related infections

6.68

7.42

1.7

1.1

—

COPD/asthma/ILD related infections

6.68

7.42

1.7

1.1

—

Immunodeficiency associated with other major defects

+∞

7.38

1.3

0.0

—

Care involving use of rehabilitation procedures

4.90

7.36

1.6

1.3

—

Disorders of tooth development and eruption

8.14

7.34

1.8

1.3

—

Defects in the complement system

+∞

7.32

1.3

0.0

—

Asthma (diagnoses ohter than nonallergic)

4.40

7.08

1.2

1.5

—

Bronchitis

5.07

7.08

1.5

1.2

—

Acute suppurative otitis media

6.23

6.96

1.5

1.3

—

Other bacterial diseases

4.38

6.92

1.4

—

Persons encountering health services for specific procedures and health care

3.85

6.90

1.5

1.3

—

Asthma/COPD (KELA code 203)

4.32

6.86

1.2

1.5

—

Any reimbursement code in KELA

8.91

6.82

1.5

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4.79

6.81

1.2

1.5

—

Disorders of psychological development

5.86

6.56

1.7

1.3

—

Asthma, hospital admissions , main diagnosis only

4.03

6.46

1.2

1.4

—

Continuous positive airway pressure

11.87

6.29

1.2

1.1

—

Other/unspecified cytomegaloviral diseases

+∞

6.26

1.2

0.0

—

Cytomegalovirus infection, IBD co-morbidity

+∞

6.26

1.2

0.0

—

Cytomegaloviral disease

+∞

6.26

1.2

0.0

—

5.50

6.19

1.2

1.5

—

Infections of the skin and subcutaneous tissue

4.65

6.16

1.4

1.5

—

Viral and other specified intestinal infections

6.51

6.12

1.2

1.6

—

Other diseases of pleura

12.66

5.94

1.5

1.0

—

Lack of expected normal physiological development

12.54

5.89

1.7

1.3

—

Other acute lower respiratory infections

4.45

5.80

1.5

1.4

—

Abnormalities of breathing

4.53

5.72

1.1

1.3

—

Childhood allergy (age < 16)

4.87

5.67

1.5

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

4.30

5.66

1.4

1.3

—

Other congenital malformations

5.89

5.62

1.1

1.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

4.07

5.60

1.4

1.3

—

Examination and observation for other reasons

9.12

5.58

1.3

1.5

—

Oral corticosteroids

4.98

5.55

1.3

1.4

—

Asthma (mode)

9.42

5.51

1.3

1.1

—

Asthma

9.19

5.42

1.3

1.1

—

Respiratory and cardiovascular disorders specific to the perinatal period

4.92

5.39

1.2

1.5

—

Other and unspecified tonsillitis

12.73

5.35

1.8

1.0

—

Transplanted organ and tissue status

11.27

5.28

1.8

1.3

—

Speech and linguistic disorders

5.04

5.22

1.7

1.3

—

Delayed milestone in childhood

5.04

5.08

1.6

1.4

—

Exclusion endpoint for clefts

13.45

5.08

1.1

1.5

—

Dental caries 2 and operation codes

3.74

5.06

1.7

1.3

—

Noninfective enteritis and colitis

4.44

5.02

1.2

1.6

—

Codes for special purposes

4.78

5.00

1.5

1.3

—

Provisional assignment of new diseases of uncertain etiology

4.78

5.00

1.5

1.3

—

Dental caries 2

3.70

4.97

1.7

1.3

—

Dyspnoea

4.12

4.95

1.1

1.6

—

Inflammatory bowel disease treatment related agents

3.65

4.94

1.6

1.4

—

Suppurative and unspecified otitis media

4.88

4.92

1.5

1.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

7.59

4.86

1.7

1.5

—

Other problems related to primary support group, including family circumstances

4.34

4.85

1.2

1.5

—

Other viral diseases

4.28

4.80

1.6

1.3

—

Slow fetal growth and fetal malnutrition

11.70

4.80

1.3

1.7

—

Asthma, excluding more controls

8.37

4.79

1.3

1.1

—

Certain infectious and parasitic diseases

3.87

4.77

1.5

1.3

—

Other noninfective gastroenteritis and colitis

5.00

4.76

1.1

1.6

—

Convulsions, not elsewhere classified

8.89

4.74

1.4

1.2

—

Headache

5.22

4.70

1.3

—

ILD medications

3.36

4.63

1.6

1.3

—

Asthma (only as main-diagnosis)

8.62

4.60

1.1

—

Disorders of other endocrine glands

3.88

4.58

1.5

1.4

—

4.89

4.58

1.1

1.5

—

Other specified congenital malformation syndromes affecting multiple systems

14.13

4.58

1.1

1.6

—

Asthma (only as main-diagnosis), excluding more controls

8.51

4.56

1.1

—

L04AX Other immunosuppressants

4.40

4.55

1.6

1.4

—

Second line medication for Crohn's disease

4.40

4.55

1.6

1.4

—

ILD medications: azathioprine

10.01

4.51

1.9

1.3

—

Azathioprine

10.01

4.51

1.9

1.3

—

Chronic sinusitis

10.00

4.51

1.3

1.8

—

Chronic lower respiratory diseases

3.18

4.48

1.4

—

Specific developmental disorder of motor function

9.92

4.47

1.8

1.4

—

Procreative management

3.92

4.45

1.4

1.3

—

Nausea and vomiting

4.68

4.42

1.4

—

Motor disorders, excluding more controls

9.65

4.39

1.8

1.3

—

Covid-19 confirmed case

7.50

4.35

1.7

1.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3.21

4.17

1.3

1.5

—

Speech and linguistic disorders, excluding more controls

7.08

4.16

1.9

1.2

—

Motor disorders

8.06

4.06

1.8

1.3

—

Nephropathy related operations

10.01

4.01

1.3

1.7

—

Diseases of pulp and periapical tissues

10.00

4.01

1.9

1.4

—

Neurological diseases, wide definition

6.14

3.99

1.5

1.2

—

Persons with potential health hazards related to communicable diseases

3.49

3.99

1.3

1.4

—

Mental retardation, excluding more controls

9.86

3.96

1.6

1.1

—

Disorders of refraction and accommodation

3.92

3.95

1.3

1.5

—

Acute bronchiolitis

4.29

3.89

1.5

1.4

—

Gastrointestinal diseases

4.07

3.89

1.6

1.2

—

Pain, not elsewhere classified

8.75

3.77

1.4

1.1

—

Acute bronchitis

3.92

3.58

1.7

1.4

—

Hypoplasia of dental enamel, including avohilmo

7.93

3.58

2.1

1.4

—

Disorders of speech understanding and production

7.66

3.51

1.4

1.6

—

Mycoses

10.00

3.49

1.3

1.7

—

Symptoms and signs concerning food and fluid intake

10.00

3.49

1.2

—

Pain in throat and chest

4.37

3.49

1.5

1.4

—

Other pulmonary diagnosis

6.44

3.44

1.7

1.1

—

Excluding asthma or asthma-COPD overlap

6.44

3.44

1.7

1.1

—

COPD differential diagnosis

6.44

3.44

1.7

1.1

—

ILD differential diagnosis

6.44

3.44

1.7

1.1

—

General symptoms and signs

3.62

3.40

1.8

1.3

—

Molar incisor enamel hypoplasia, with caries

7.13

3.37

2.1

1.4

—

Sleep disorders (combined)

3.79

3.36

1.2

1.6

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

7.02

3.36

1.1

1.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

3.72

3.34

1.3

1.5

—

Metabolic disorders

3.36

3.34

1.1

1.5

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

6.85

3.31

1.9

1.7

—

Respiratory distress of newborn

4.97

3.30

1.2

1.5

—

Specific development disorders of speech and language

6.75

3.27

1.6

1.4

—

Invasive ventilation

8.59

3.26

1.3

1.1

—

Other respiratory disorders and diseases

8.58

3.26

1.7

1.0

—

Other diseases of the respiratory system

8.58

3.26

1.7

1.0

—

Other disorders of lacrimal gland

8.57

3.26

1.7

1.4

—

Chronic kidney disease

8.53

3.25

1.2

1.7

—

First line medication for Crohn's disease

2.81

3.20

1.5

1.4

—

Conjunctivitis

2.90

3.17

1.7

1.3

—

Dental caries

5.28

3.16

2.0

1.3

—

Dentofacial anomalies [including malocclusion]

5.28

3.16

1.4

1.3

—

Certain conditions originating in the perinatal period

4.70

3.15

1.4

1.5

—

Bacterial Sepsis

6.23

3.08

1.9

1.2

—

Other diseases of hard tissues of teeth

3.42

3.06

1.8

1.3

—

Cellulitis

7.50

3.05

1.7

1.5

—

Osteopathies and chondropathies

5.06

3.05

1.5

1.6

—

Antihypertensive medication - note that there are other indications

2.93

3.04

1.5

1.4

—

Acute tubulo-interstitial nephritis

3.25

2.99

1.5

1.4

—

Molar incisor enamel hypoplasia

4.22

2.94

1.9

1.3

—

Other endocrine disorders

4.14

2.88

1.3

1.4

—

L04AD Calcineurin inhibitors

5.39

2.87

1.6

1.5

—

Disorders of lacrimal system

6.67

2.86

1.7

—

Renal failure

6.85

2.86

1.2

1.8

—

Personal history of other diseases and conditions

5.37

2.85

1.4

1.2

—

Dorsopathies

2.98

2.84

1.4

—

Disorders of conjunctiva

2.73

2.84

1.7

1.3

—

Atopic dermatitis, strict definition

3.08

2.82

1.5

1.3

—

General examination and investigation of persons without complaint and reported diagnosis

5.32

2.82

1.1

1.5

—

Tonsillectomy and adenotomy

2.68

2.82

1.4

—

Other diseases of upper respiratory tract

2.69

2.79

1.4

—

Asthma, including avohilmo

2.53

2.75

1.4

—

Other/unspecified dorsalgia

8.29

2.74

1.6

2.0

—

Specific development disorders of scholastic skills

8.25

2.73

1.8

1.7

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4.36

2.72

1.3

1.5

—

Persons encountering health services in circumstances related to reproduction

2.84

2.69

1.7

1.3

—

Dorsalgia

3.31

2.66

1.5

1.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.95

2.65

1.5

1.4

—

Chronic diseases of tonsils and adenoids

2.84

2.63

1.3

1.4

—

Diseases of the respiratory system

5.85

2.62

1.4

1.2

—

Genitourinary diseases

2.81

2.59

1.5

1.4

—

Other viral diseases, not elsewhere classified

3.59

2.56

1.8

1.3

—

Congenital malformations of aortic and mitral valves

7.16

2.55

1.6

—

Embedded teeth, including avohilmo

7.15

2.55

1.6

2.0

—

Dialysis, with operation codes

7.15

2.55

1.6

1.7

—

Diseases of liver

7.14

2.55

1.4

1.7

—

Allergic conjunctivitis

3.54

2.53

1.7

1.4

—

Short stature, not elsewhere classified

3.97

2.52

1.4

—

Malaise and fatigue

5.56

2.49

1.5

1.1

—

Cardiovascular diseases

2.49

2.48

1.4

—

Other and unspecified anaemias

5.28

2.47

1.0

1.3

—

Mental retardation

4.39

2.47

1.6

1.4

—

Mental retardation, wide definition

4.38

2.47

1.6

1.4

—

Other anaemias

5.26

2.47

1.0

1.3

—

Hypoplasia of dental enamel , including avohilmo

4.34

2.45

2.1

1.4

—

Nonsuppurative otitis media

3.84

2.43

1.5

1.3

—

Substance abuse, excluding more controls

5.25

2.43

1.2

1.5

—

Parasetamol

3.83

2.42

1.4

1.7

—

Cutaneous abscess, furuncle and carbuncle

5.00

2.40

1.5

—

Congenital malformations of the circulatory system

3.36

2.39

1.3

1.5

—

Congenital malformations of heart and great arteries

3.35

2.39

1.3

1.5

—

Crossbite

3.71

2.38

1.5

—

Impetigo

6.26

2.37

1.0

1.5

—

Other diseases of blood and blood-forming organs, wide

6.25

2.37

1.6

1.5

—

Other dorsopathies, not elsewhere classified

3.05

2.36

1.4

—

Other congenital malformations of the digestive system

4.10

2.34

1.3

1.4

—

Asthma, unspecified (mode)

6.60

2.34

1.2

1.0

—

Asthma, unspecified (mode), excluding more controls

6.54

2.33

1.2

1.0

—

STROKE

5.20

2.31

1.5

1.6

—

Aplastic and other anaemias

4.74

2.29

1.0

1.3

—

Psychiatric diseases

2.60

2.29

1.6

1.3

—

Any mental disorder

2.60

2.29

1.6

1.3

—

Other disorders of ear

2.66

2.23

1.5

1.4

—

Medical observation and evaluation for suspected diseases and conditions

4.48

2.23

1.3

1.5

—

Cardiovascular diseases (excluding rheumatic etc)

2.41

2.23

1.5

1.4

—

Tooth eruption problems

3.85

2.23

1.4

1.6

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3.42

2.22

1.7

1.3

—

Other diseases of intestines

2.32

2.22

1.3

1.4

—

Viral infections characterized by skin and mucous membrane lesions

3.10

2.22

1.6

1.4

—

Sleep disorders

5.56

2.21

1.2

1.7

—

Systemic connective tissue disorders

5.56

2.21

2.0

1.4

—

Astigmatism

5.56

2.21

1.4

1.8

—

Persons encountering health services in other circumstances, wide

2.43

2.21

1.3

1.5

—

Other disorders starting during childhood or adolecense, excluding more controls

4.46

2.20

1.7

1.2

—

Cerebrovascular diseases (FINNGEN)

4.77

2.20

1.7

1.6

—

Bacterial infection, other or unspecified

4.51

2.20

1.5

1.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.92

2.19

1.4

1.5

—

Tramadol

4.09

2.18

1.1

1.5

—

Other nutritional deficiencies

3.03

2.16

1.3

1.5

—

Renal tubulo-interstitial diseases

2.56

2.15

1.4

—

Temporomandibular joint disorders, including avohilmo

3.68

2.14

1.3

1.5

—

Cerebrovascular diseases

3.86

2.13

1.6

1.5

—

Gingivitis and periodontal diseases

3.04

2.12

1.6

1.4

—

Left ventricular outflow tract obstruction, narrow definition

5.01

2.07

1.6

1.4

—

Dental caries 2, only avohilmo

2.49

2.07

1.8

1.3

—

Substance abuse

4.10

2.06

1.2

1.8

—

Dentinal caries

4.98

2.06

2.4

1.4

—

Autoimmune diseases related-to ILD

2.93

2.06

1.4

1.5

—

Vasomotor and allergic rhinitis

3.15

2.06

1.3

1.4

—

Diseases of middle ear and mastoid

2.95

2.05

1.6

1.4

—

Use of hypnotics and sedatives

2.89

2.05

1.4

—

Stroke, excluding SAH

5.31

2.04

1.6

1.1

—

Mental and behavioural disorders due to psychoactive substance use

4.04

2.04

1.2

1.8

—

Disorders of eyelid, lacrimal system and orbit

2.94

2.03

1.4

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.46

2.02

1.6

1.4

—

Sensorineural hearing loss

4.20

2.00

1.2

1.5

—

Symptoms and signs involving the skin and subcutaneous tissue

3.06

2.00

1.1

1.5

—

Hard cardiovascular diseases

4.28

2.00

1.5

1.7

—

Haemorrhagic and haematological disorders of fetus and newborn

3.08

1.99

1.3

1.4

—

Implicit Sepsis

3.11

1.97

1.6

1.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.84

1.94

1.7

1.3

—

L04AA Selective immunosuppressants

4.55

1.94

1.6

1.4

—

Other arthritis (FG)

4.55

1.94

1.2

1.7

—

Urticaria and erythema

2.96

1.93

1.1

1.5

—

Embedded and impacted teeth

3.31

1.91

1.6

1.4

—

Stroke, including SAH

4.62

1.87

1.6

1.4

—

Epilepsy

2.85

1.85

1.8

1.4

—

Contact with and exposure to communicable diseases

2.64

1.85

1.4

—

Other reaction to severe stress, and adjustment disorders

3.53

1.83

1.5

1.6

—

Dental caries 2 and operation codes, only avohilmo

2.40

1.83

1.8

1.3

—

Focal epilepsy

3.53

1.83

1.7

1.5

—

Other diseases of urinary system

2.25

1.83

1.4

—

Direct fill therapy

4.17

1.82

2.4

1.3

—

Congenital malformations of great arteries

3.48

1.80

1.5

—

Intracranial trauma

2.85

1.78

1.4

1.3

—

Other disorders starting during childhood or adolescence

3.02

1.78

1.6

1.4

—

Concussion

3.03

1.76

1.1

1.4

—

Other intervertebral disc disorders

4.37

1.74

1.2

1.1

—

Congenital malformations of cardiac septa

2.95

1.73

1.4

—

Anxiety disorders, excluding more controls

3.09

1.73

1.4

—

Hypermetropia

3.85

1.71

1.4

1.5

—

Focal epilepsy, strict definition

3.85

1.71

1.8

1.5

—

Low back pain

2.99

1.71

1.4

—

Paroxysmal tachycardia

3.84

1.67

1.6

—

Complications of procedures, not elsewhere classified

2.88

1.67

1.3

1.5

—

All anxiety disorders

2.68

1.53

1.3

1.5

—

Opioids

2.63

1.53

1.1

1.7

—

Anxiety (asthma-related co-morbidities)

2.63

1.49

1.3

1.6

—

Cystitis

2.24

1.48

1.3

1.4

—

Bacterial pneumonia (organism specified)

3.25

1.47

1.8

1.5

—

Atrial septal defect

3.11

1.43

1.6

1.5

—

Hernia

2.35

1.42

1.2

1.5

—

Cardiac arrhythmias

2.57

1.42

1.4

1.5

—

Diseases of the eye and adnexa

2.15

1.40

1.7

1.3

—

Neurotic, stress-related and somatoform disorders

2.28

1.39

1.3

1.5

—

Anxiety disorders

2.28

1.39

1.3

1.5

—

Conductive and sensorineural hearing loss

2.77

1.39

1.2

1.5

—

Visual disturbances and blindness

2.41

1.39

1.3

1.5

—

Mouth breathing

2.41

1.39

1.1

1.4

—

Other (not insulin) diabetes medications

2.78

1.37

1.0

1.2

—

Sleep apnoea

2.71

1.36

1.3

1.5

—

Congenital malformations and deformations of the musculoskeletal system

2.60

1.36

1.3

1.5

—

Type 2 diabetes, strict (exclude DM1)

2.75

1.35

1.0

1.2

—

Type 2 diabetes, definitions combined

2.75

1.35

1.0

1.2

—

Symptoms and signs involving the digestive system and abdomen

2.04

1.35

1.3

1.4

—

Inguinal hernia

2.70

1.35

1.3

—

Transport accidents

2.96

1.34

1.4

1.5

—

Type 2 diabetes

2.74

1.34

1.0

1.2

—

Type 2 diabetes, definitions combined, including avohilmo

2.73

1.34

1.0

1.2

—

Parodontitis and operation codes

2.99

1.33

1.4

1.5

—

Depression or dysthymia

3.11

1.31

1.4

—

Pain in joint

3.01

1.31

1.4

1.3

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.43

1.31

1.5

1.3

—

Exposure to other specified factors

2.11

1.30

1.2

1.5

—

Other functional intestinal disorders

2.38

1.29

1.5

—

Obesity

2.48

1.28

1.5

—

Obesity and other hyperalimentation

2.47

1.28

1.5

—

Persons encountering health services in other circumstances

2.78

1.28

1.2

1.6

—

Allergic rhinitis

2.33

1.28

1.4

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.40

1.24

1.7

1.4

—

Reimbursement for rheumatic diseases

2.39

1.24

1.0

1.6

—

Anaemias

2.49

1.24

1.3

1.1

—

Dermatitis due to ingested food

2.68

1.23

1.0

1.4

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2.72

1.23

1.0

1.5

—

Other disorders of skin and subcutaneous tissue

2.39

1.22

1.2

1.6

—

Other and unspecified effects of external causes

2.63

1.21

1.2

1.5

—

Other and unspecified dermatitis

2.63

1.21

1.6

1.5

—

Heart failure, not strict

2.43

1.21

1.5

1.4

—

Biguanides

2.46

1.21

1.0

1.4

—

Other anxiety disorders

2.61

1.19

1.2

1.6

—

Chronic periodontitis, including avohilmo

2.64

1.18

1.4

1.5

—

Complications of surgical and medical care, not elsewhere classified

2.12

1.17

1.4

—

Parodontitis

2.63

1.17

1.4

1.5

—

Parodontitis or operation codes

2.63

1.17

1.4

1.5

—

Polyarthropathies

2.46

1.15

1.1

1.5

—

Diseases of oral cavity, salivary glands and jaws

2.02

1.14

1.5

1.3

—

Dental pulpitis 3

2.40

1.14

1.7

1.4

—

Injuries to the ankle and foot

2.02

1.13

1.4

1.5

—

Diseases of the skin and subcutaneous tissue

2.09

1.12

1.6

1.4

—

Neurological diseases

1.87

1.11

1.4

1.3

—

Neonatal jaundice from other and unspecified causes

2.43

1.11

1.0

1.4

—

Other antidepressants

2.28

1.09

1.0

1.6

—

Excessive, frequent and irregular menstruation

2.53

1.08

1.4

1.5

—

Atopic dermatitis, strict definition with reimbursement

2.12

1.05

1.7

1.3

—

Disorders of skin appendages

2.27

1.03

1.2

1.5

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.27

1.03

1.6

—

Intracranial injury

2.05

1.02

1.1

1.5

—

Benzodiazepine use

2.08

1.02

1.0

1.5

—

Unspecified fall

2.04

1.02

1.6

1.4

—

Pollen allergy

2.04

1.01

1.4

—

Dizziness and giddiness

2.25

1.00

1.6

—

Migraine

2.24

1.00

1.4

1.5

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.00

1.00

1.6

1.4

—

Nutritional anaemias

2.21

1.00

1.4

1.5

—

Noninflammatory disorders of female genital tract

2.52

0.99

1.5

—

Hypertensive diseases (excluding secondary)

2.03

0.98

1.4

1.6

—

Pain in limb

1.90

0.98

1.5

1.4

—

Behavioural syndromes associated with physiological disturbances and physical factors

2.17

0.98

1.2

1.5

—

Pregnancy with abortive outcome

2.41

0.97

1.2

1.5

—

Endocrine, nutritional and metabolic diseases

1.87

0.95

1.3

1.4

—

Other disorders of urethra and urinary system

2.25

0.94

1.3

1.5

—

Urticaria

2.22

0.93

1.2

1.5

—

Diseases of the digestive system

2.22

0.93

1.3

1.4

—

Gastro-oesophageal reflux disease

2.13

0.91

1.3

1.4

—

Conjunctivitis (acute, non atopic)

2.06

0.89

1.7

1.3

—

Atopic dermatitis

1.84

0.86

1.6

1.3

—

Abdominal and pelvic pain

1.78

0.84

1.3

1.4

—

Delivery

0.00

0.83

0.0

1.6

—

Single spontaneous delivery

0.00

0.83

0.0

1.6

—

Dermatitis and eczema

1.72

0.80

1.5

1.3

—

Other arrhythmias

2.25

0.77

1.0

1.6

—

Diseases of the musculoskeletal system and connective tissue

1.74

0.77

1.9

1.2

—

Injuries to the wrist and hand

1.67

0.75

1.6

1.4

—

Lower back pain or/and sciatica

1.87

0.74

1.4

1.5

—

Dermatitis

2.08

0.74

1.6

1.4

—

Arthropathies

1.70

0.74

1.3

1.5

—

Medical abortion

2.09

0.74

1.2

1.5

—

Irregular menses

2.03

0.73

1.2

1.5

—

Hypertension

1.80

0.72

1.4

1.5

—

Visual disturbances

2.00

0.72

1.4

1.6

—

Dental operations

1.97

0.70

1.0

1.2

—

Hypertensive diseases

1.72

0.70

1.4

1.5

—

Septal defects

1.88

0.69

1.2

1.4

—

Other heart diseases

1.65

0.67

1.6

1.5

—

Diseases of the ear and mastoid process

1.69

0.66

1.5

1.3

—

Sleep apnoea, including avohilmo

1.80

0.65

1.2

1.4

—

Other external causes of accidental injury

1.67

0.64

1.4

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.71

0.62

1.0

1.5

—

Other soft tissue disorders, not elsewhere classified

1.63

0.62

1.5

1.4

—

Artificial joint operation, meniscal resection

0.00

0.61

0.0

1.5

—

Diabetes, varying definitions

1.54

0.59

1.4

1.5

—

Diabetes mellitus

1.54

0.59

1.4

1.5

—

Episodal and paroxysmal disorders

1.54

0.59

1.6

1.3

—

Diabetes medication

1.52

0.58

1.4

—

Diseases of oesophagus, stomach and duodenum

1.52

0.58

1.3

1.4

—

Polycystic ovarian syndrome, consortium definition

1.72

0.58

1.2

1.5

—

Accidents

1.50

0.55

1.4

1.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.53

0.54

1.5

1.3

—

Exposure to unspecified factor

1.45

0.53

1.3

1.4

—

Autoimmune diseases excluding thyroid diseases

1.49

0.49

1.5

1.3

—

Pain (limb, back, neck, head abdominally)

1.48

0.44

1.6

1.2

—

Other joint disorders

1.47

0.44

1.3

1.4

—

Hypothyroidism, strict autoimmune

1.65

0.44

1.4

1.5

—

Pregnancy, childbirth and the puerperium

0.00

0.43

0.0

1.5

—

Delivery, wide proxy

0.00

0.42

0.0

1.5

—

Soft tissue disorders

1.43

0.41

1.5

1.4

—

False labour

0.00

0.41

0.0

1.5

—

Other specific joint derangements/joint disorders

1.40

0.38

1.4

1.5

—

Other heart diseases, wide

1.33

0.38

1.4

—

Used for control exclusion in common control thyroid runs

1.36

0.33

1.5

1.3

—

Injury, poisoning and certain other consequences of external causes

1.40

0.33

1.3

1.4

—

Finngen Rheumatological endpoints

1.29

0.30

1.6

1.5

—

Injuries to the knee and lower leg

1.29

0.26

1.4

—

Dental pulpitis 1

1.26

0.26

1.8

1.4

—

Diseases of pulp and periapical tissues, including avohilmo

1.26

0.26

1.8

1.4

—

Dental pulpitis 4

1.26

0.26

1.8

1.4

—

Selective serotonin reuptake inhibitors

1.39

0.24

1.0

1.6

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.31

0.23

1.4

1.5

—

Diabetic retinopathy

0.00

0.22

0.0

1.4

—

Injuries to the elbow and forearm

1.22

0.22

1.0

1.5

—

Rotator cuff syndrome

0.00

0.22

0.0

1.3

—

Transient ischemic attack

0.00

0.21

0.0

1.7

—

Depression

1.19

0.21

1.4

1.5

—

Long labour

0.00

0.21

0.0

1.4

—

Pain and other conditions associated with female genital organs and menstrual cycle

0.00

0.21

0.0

1.5

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.21

0.0

1.4

—

Haemorrhage in early pregnancy

0.00

0.21

0.0

1.2

—

Maternal care for known or suspected abnormality of pelvic organs

0.00

0.21

0.0

1.4

—

Wide developmental disorders

0.00

0.21

0.0

1.4

—

Open bite

0.00

0.21

0.0

1.6

—

Phobic anxiety disorders

0.00

0.21

0.0

1.7

—

Pedal cyclist injured in transport accident

0.00

0.21

0.0

1.7

—

Schizophrenia or delusion

0.00

0.21

0.0

1.6

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.21

0.0

1.6

—

Kela-code for severe mental illness

0.00

0.21

0.0

1.5

—

Overjet

0.00

0.21

0.0

1.7

—

Suicide or other Intentional self-harm

0.00

0.21

0.0

1.7

—

Pre-eclampsia or poor fetal growth

0.00

0.21

0.0

1.3

—

Superficial injury of head

0.00

0.21

0.0

1.4

—

Distal bite

0.00

0.20

0.0

1.8

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.22

0.20

1.5

—

Autoimmune diseases

1.25

0.18

1.5

1.3

—

Injuries to the head

1.17

0.15

1.2

1.4

—

Fall on same level

0.78

0.15

1.3

1.4

—

Hypothyroidism, other/unspecified

1.14

0.10

1.4

1.5

—

Dental pulpitis 2

1.11

0.10

1.6

1.2

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1.09

0.10

2.0

1.3

—

Malignant neoplasm, wide definition for exclusion

1.09

0.10

2.0

1.3

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1.09

0.10

2.0

1.3

—

Mood [affective] disorders

1.10

0.10

1.4

1.5

—

Mood disorders

1.09

0.10

1.4

1.5

—

Dental pulpitis 2, only avohilmo

1.07

0.09

1.6

1.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.06

0.09

1.4

1.5

—

Dental caries 1 and operation codes

1.14

0.09

1.5

1.3

—

Diabetes, insulin treatment (Kela reimbursement)

1.15

0.09

1.5

1.4

—

External causes of morbidity and mortality

1.11

0.09

1.3

1.4

—

Dental pulpitis 4, only avohilmo

0.85

0.08

1.5

—

Dental pulpitis 1, only avohilmo

0.85

0.08

1.5

—

Neoplasms

1.10

0.07

1.7

1.3

—

Falls/tendency to fall

1.02

0.07

1.4

1.3

—

Diabetic retinopathy, strict definition

0.00

0.0

1.5

—

GI-bleeding

0.00

0.0

1.4

—

Liveborn infants according to place of birth

0.00

0.0

1.3

—

All-cause Heart Failure

0.00

0.0

1.4

—

Anorexia (incl.atypical)

0.00

0.0

1.8

—

Trigger finger

0.00

0.0

1.0

—

Fall involving playground equipment

0.00

0.0

1.6

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.0

1.6

—

Hydrocele

0.00

0.0

1.5

—

Benign neoplasm: Colon

0.00

0.0

1.4

—

Medicines for HER+ breast cancer

0.00

0.0

1.4

—

Prolonged pregnancy

0.00

0.0

1.2

—

Injury of unspecified body region

0.00

0.0

1.6

—

Otitis externa

0.00

0.0

1.6

—

Thyrotoxicosis, other and/or unspecified

0.00

0.0

1.8

—

Coronary atherosclerosis

0.00

0.0

1.6

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

0.00

0.0

1.8

—

Social phobias

0.00

0.0

1.8

—

Diabetic nephropathy, excluding more controls

0.00

0.0

1.6

—

Gestational [pregnancy-induced] hypertension

0.00

0.0

1.3

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Carcinoma in situ of cervix uteri

0.00

0.0

1.2

—

Post-traumatic stress disorder

0.00

0.0

1.6

—

Benign neoplasms

1.01

0.00

1.3

1.4

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

0.0

1.4

—

Heart failure,strict

0.00

0.0

1.6

—

Major coronary heart disease event excluding revascularizations

0.00

0.0

1.7

—

Obsessive-compulsive disorder

0.00

0.0

1.4

—

Benign neoplasms

1.03

0.00

1.3

—

Carcinoma in situ of cervix uteri

0.00

0.0

1.2

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.0

1.8

—

Benign neoplasm: Colon

0.00

0.0

1.3

—

Exclusions for E4_PCOS_CONSORTIUM

0.96

0.00

1.3

1.5

—

Thyrotoxicosis with diffuse goitre

0.00

0.0

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

0.00

0.0

1.4

—

Migraine without aura and triptan purchases

0.00

0.0

1.9

—

Other and unspecified nonorganic psychotic disorders

0.00

0.0

1.6

—

Mandibular retrognathia

0.00

0.0

2.0

—

Fracture of skull and facial bones

0.00

0.0

1.0

—

Poor fetal growth

0.00

0.0

1.2

—

Diabetic nephropathy

0.00

0.0

1.6

—

Dental caries 1, only avohilmo

0.88

0.00

1.6

1.2

—

Other disorders of eye and adnexa

0.00

0.0

1.5

—

Dental caries, including avohilmo

0.98

0.00

1.6

1.2

—

Dental caries 1

0.98

0.00

1.6

1.2

—

Abnormalities of forces of labour

0.00

0.0

1.6

—

Constipation

0.95

0.00

1.5

1.4

—

Endometriosis ASRM stages 3,4

0.00

0.0

1.5

—

Diaphragmatic hernia

0.00

0.0

1.4

—

Wide developmental disorders, excluding more controls

0.00

0.0

1.2

—

Heart failure, strict

0.00

0.0

1.4

—

Benign neoplasm of colon, rectum, anus and anal canal

0.00

0.0

1.3

—

Outcome of delivery

0.00

0.0

1.5

—

Disorders of the thyroid gland

1.02

0.00

1.4

—

Subjective visual disturbances

0.00

0.0

1.6

—

Bipolar affective disorders

0.00

0.0

1.4

—

Emotionally unstable personality disorder

0.00

0.0

1.6

—

Retinal detachments and breaks

0.00

0.0

1.4

—

Persistent mood disorders

0.00

0.0

1.4

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.0

1.6

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Superficial injury of forearm

0.00

0.0

1.7

—

Malignant neoplasm of breast, HER-positive

0.00

0.0

1.5

—

Atrial fibrillation and flutter

0.00

0.0

2.0

—

L02BG Aromatase inhibitors

0.00

0.0

1.6

—

Gonarthrosis, primary, with knee surgery

0.00

0.0

1.4

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

0.0

1.2

—

Schizophrenia or delusion, excluding more controls

0.00

0.0

1.7

—

Ganglion

0.00

0.0

1.4

—

Other disorders of patella

0.00

0.0

1.9

—

Hypertrophy of breast in women and men

0.00

0.0

1.3

—

Hypertrophy of breast

0.00

0.0

1.3

—

Congenital malformations of larynx

0.00

0.0

1.8

—

Abnormal findings on antenatal screening of mother

0.00

0.0

1.0

—

Fracture of foot, except ankle

0.00

0.0

1.9

—

Soft tissue disorders related to use, overuse and pressure

0.00

0.0

1.0

—

Pre-eclampsia or eclampsia

0.00

0.0

1.4

—

Coxarthrosis

0.00

0.0

1.3

—

Thyrotoxicosis

0.00

0.0

1.7

—

Pre-eclampsia

0.00

-0.00

0.0

1.4

—

Injury of eye and orbit

0.00

-0.00

0.0

1.8

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Haemophilus influenzae B Ab [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS